During the past decade, Second Affiliated Hospital Chongqing Medical University conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Second Affiliated Hospital Chongqing Medical University" #1 sponsor was "The Second Affiliated Hospital of Chongqing Medical University" with 5 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Xiamen Amoytop Biotech Co., Ltd." with 3 trials sponsored, "First Affiliated Hospital of Chongqing Medical University" with 2 trials sponsored and "Hong Ren" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Second Affiliated Hospital Chongqing Medical University" #1 collaborator was "First Affiliated Hospital of Chongqing Medical University" with 3 trials as a collaborator, "Guangdong Provincial People's Hospital" with 3 trials as a collaborator, "Cancer Institute and Hospital, Chinese Academy of Medical Sciences" with 2 trials as a collaborator, "Fudan University" with 2 trials as a collaborator and "Nanfang Hospital of Southern Medical University" with 2 trials as a collaborator. Other collaborators include 58 different institutions and companies that were collaborators in the rest 67 trials.

According to Clinical.Site data, the most researched conditions in "Second Affiliated Hospital Chongqing Medical University" are "Atrial Fibrillation" (3 trials), "Chronic Hepatitis B" (2 trials), "Chronic Hepatitis C" (2 trials), "Hypertension" (2 trials) and "Anemia Associated Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "Second Affiliated Hospital Chongqing Medical University" in a lesser frequency.

Most popular intervention types in "Second Affiliated Hospital Chongqing Medical University" are "Drug" (15 trials), "Other" (5 trials), "Procedure" (5 trials), "Device" (4 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Ypeginterferon alfa-2b" (3 trials), "BI 685509" (2 trials), "Pegasys" (2 trials) and "acupoint stimulation" (2 trials). Other intervention names were less common.

The vast majority of trials in "Second Affiliated Hospital Chongqing Medical University" are 29 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are 11 active trials in "Second Affiliated Hospital Chongqing Medical University". 1 are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 10 completed trials in Second Affiliated Hospital Chongqing Medical University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Second Affiliated Hospital Chongqing Medical University, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 7 trials that are defined as “Not Applicable".